Structure Therapeutics Inc.
GPCR
$19.61
$0.241.24%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -178.95M | -143.32M | -122.53M | -110.55M | -100.44M |
| Total Depreciation and Amortization | 1.11M | 1.05M | 996.00K | 819.00K | 626.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.44M | 3.16M | 1.93M | 1.61M | 1.78M |
| Change in Net Operating Assets | 9.45M | 4.33M | 2.96M | 6.22M | -4.73M |
| Cash from Operations | -162.95M | -134.79M | -116.64M | -101.90M | -102.76M |
| Capital Expenditure | -1.25M | -1.44M | -1.29M | -2.43M | -2.57M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -71.59M | -324.85M | -357.62M | -570.46M | -351.15M |
| Cash from Investing | -72.84M | -326.29M | -358.91M | -572.89M | -353.71M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.49M | 517.27M | 517.06M | 816.56M | 816.64M |
| Repurchase of Common Stock | -156.00K | -156.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.15M | -1.74M | -1.80M | -20.28M | -19.13M |
| Cash from Financing | 1.18M | 515.37M | 515.26M | 796.28M | 797.51M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -234.60M | 54.29M | 39.72M | 121.49M | 341.04M |